SIENNA BIOPHARMACEUTICALS IN's ticker is SNNAQ and the CUSIP is 82622H108. A total of 49 filers reported holding SIENNA BIOPHARMACEUTICALS IN in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $101,000 | 0.0% | 43,341 | -0.7% | 0.00% | – |
| Q4 2018 | $101,000 | -84.4% | 43,627 | 0.0% | 0.00% | – |
| Q3 2018 | $647,000 | +15.3% | 43,627 | +18.1% | 0.00% | – |
| Q2 2018 | $561,000 | -6.7% | 36,945 | +15.5% | 0.00% | – |
| Q1 2018 | $601,000 | +113.9% | 31,989 | +106.6% | 0.00% | – |
| Q4 2017 | $281,000 | +2.6% | 15,481 | +25.5% | 0.00% | – |
| Q3 2017 | $274,000 | – | 12,337 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 758,610 | $660,000 | 0.17% |
| Wildcat Capital Management, LLC | 295,613 | $257,000 | 0.11% |
| Golden State Wealth Management, LLC | 180,552 | $157,000 | 0.05% |
| PFM Health Sciences, LP | 2,583,712 | $2,248,000 | 0.04% |
| Cohen Capital Management, Inc. | 108,010 | $94,000 | 0.02% |
| Partner Investment Management, L.P. | 13,260 | $12,000 | 0.01% |
| Coastal Bridge Advisors, LLC | 21,115 | $18,000 | 0.01% |
| A.R.T. Advisors, LLC | 32,653 | $28,000 | 0.00% |
| Ballentine Partners, LLC | 16,700 | $15,000 | 0.00% |
| CLIFFORD SWAN INVESTMENT COUNSEL LLC | 15,000 | $13,000 | 0.00% |